Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANE SHEETS

v3.19.2
CONDENSED CONSOLIDATED BALANE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 111,115 $ 96,473
Accounts receivable, net 148,287 143,907
Inventory, net 48,293 42,299
Other current assets and prepaid expenses 36,533 35,052
Total current assets 344,228 317,731
Property, plant and equipment, net 137,106 144,674
Intangible assets, net 581,306 614,452
In-process research and development 635,569 635,572
Goodwill 699,842 700,193
Investments 24,767 31,228
Operating lease right-of-use assets 29,640  
Other assets 3,770 7,222
Total assets 2,456,228 2,451,072
Current liabilities:    
Accounts payable 60,376 47,395
Accrued expenses 198,382 203,513
Current maturities of operating leases 13,376  
Current portion of convertible notes 0 31,562
Current portion of lines of credit and notes payable 11,240 5,851
Total current liabilities 283,374 288,321
Operating lease liabilities 16,673  
Convertible notes 206,165 57,299
Deferred tax liabilities, net 113,334 115,193
Other long-term liabilities, principally contract liabilities, contingent consideration and line of credit 127,751 198,968
Total long-term liabilities 463,923 371,460
Total liabilities 747,297 659,781
Equity:    
Common Stock - $0.01 par value, 1,000,000,000 and 750,000,000 shares authorized at June 30, 2019 and December 31, 2018, respectively; 616,150,952 and 586,881,720 shares issued at June 30, 2019 and December 31, 2018, respectively 6,162 5,869
Treasury Stock - 549,907 and 549,907 shares at June 30, 2019 and December 31, 2018, respectively (1,791) (1,791)
Additional paid-in capital 3,061,631 3,004,422
Accumulated other comprehensive loss (20,351) (20,131)
Accumulated deficit (1,336,720) (1,197,078)
Total shareholders’ equity 1,708,931 1,791,291
Total liabilities and equity $ 2,456,228 $ 2,451,072